Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Mahaffey

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|September 25, 2023
Training New DMC Members: A Call to ActionFrank Rockhold, Kenneth Mahaffey, David DeMets
American Journal of Preventive Cardiology|March 29, 2024
Relationship between body mass index and cardiometabolic health in a multi-ethnic population: A project baseline health studyNishant P Shah, Rong Lu, Francois Haddad, et al.
The American Journal of Cardiology|November 7, 2016
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery DiseaseMichael Domanski, Michael E Farkouh, Victor Zak, et al.
The American Journal of Cardiology|September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomesChristopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
Journal of the American Heart Association|July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registryEmil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.
Diabetes, Obesity & Metabolism|May 22, 2020
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialClare Arnott, Yuli Huang, Brendon L Neuen, et al.
BMJ Open|December 21, 2019
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)Nobuhiro Ikemura, John A Spertus, Takehiro Kimura, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 25, 2023
Training New DMC Members: A Call to ActionFrank Rockhold, Kenneth Mahaffey, David DeMets
American Journal of Preventive Cardiology|March 29, 2024
Relationship between body mass index and cardiometabolic health in a multi-ethnic population: A project baseline health studyNishant P Shah, Rong Lu, Francois Haddad, et al.
The American Journal of Cardiology|November 7, 2016
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery DiseaseMichael Domanski, Michael E Farkouh, Victor Zak, et al.
The American Journal of Cardiology|September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomesChristopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
Journal of the American Heart Association|July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registryEmil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.
Diabetes, Obesity & Metabolism|May 22, 2020
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialClare Arnott, Yuli Huang, Brendon L Neuen, et al.
BMJ Open|December 21, 2019
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)Nobuhiro Ikemura, John A Spertus, Takehiro Kimura, et al.
Pageof 2